Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Practice Point
  • Published:

Which treatment should patients with high-risk T1G3 bladder cancer receive?

Nature Clinical Practice Urology volume 5, pages 414–415 (2008)Cite this article

Kulkarni GS et al. (2007) Optimal management of high-risk T1G3 bladder cancer: a decision analysis. PLoS Med 4: 1538–1549

Background

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

References

  1. Herr HW (2005) Surgical factors in the treatment of superficial and invasive bladder cancer. Urol Clin North Am 32: 157–164

    Article  Google Scholar 

  2. Masood S et al. (2004) T1G3 bladder cancer—indications for early cystectomy. Int Urol Nephrol 36: 41–44

    Article  CAS  Google Scholar 

  3. Quek ML et al. (2005) Prognostic significance of lymphovascular invasion of bladder cancer treated with radical cystectomy. J Urol 174: 103–106

    Article  Google Scholar 

  4. Orsola A et al. (2005) Initial high-grade T1 urothelial cell carcinoma: feasibility and prognostic significance of lamina propria invasion microstaging (T1a/b/c) in BCG-treated and BCG-non-treated patients. Eur Urol 48: 231–238

    Article  CAS  Google Scholar 

Download references

Acknowledgements

With regret, we announce that JP Stein passed away before the publication of this article. The synopsis was written by Rachel Murphy, Associate Editor, Nature Clinical Practice.

Author information

Authors and Affiliations

  1. GJ Huang is a Fellow in Urologic Oncology and JP Stein was a Professor at the Department of Urology, University of Southern California Keck School of Medicine, Los Angeles, CA, USA.,

    George J Huang & John P Stein

Authors
  1. George J Huang
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. John P Stein
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to George J Huang.

Ethics declarations

Competing interests

The authors declare no competing financial interests.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Huang, G., Stein, J. Which treatment should patients with high-risk T1G3 bladder cancer receive?. Nat Rev Urol 5, 414–415 (2008). https://doi.org/10.1038/ncpuro1149

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/ncpuro1149

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing